Table 2.
All Institutions | GCRCs | SPOREs | |
---|---|---|---|
Protocol Characteristics | n = 139 | n = 115 | n = 24 |
Sponsor | |||
Government | 104 (74.8%) | 86 (74.8%) | 18 (75%) |
Industry | 18 (13.0%) | 17 (14.8%) | 1 (4.2%) |
Other | 5 (3.6%) | 3 (2.6%) | 2 (8.3%) |
Missing | 12 (8.6%) | 9 (7.8%) | 3 (12.5%) |
Study type | |||
Nontreatment | 67 (48.2%) | 64 (55.7%) | 3 (12.5%) |
Tissue procurement/banking only | 25 (18.0%) | 6 (5.2%) | 19 (79.2%) |
Treatment | 46 (33.1%) | 45 (39.1%) | 1 (4.2%) |
Other | 1 (0.7%) | 0 (0.0%) | 1 (4.2%) |
Human biological materials collection | |||
Prospective | 127 (91.4%) | 112 (97.4%) | 15 (62.5%) |
Existing | 7 (5.0%) | 2 (1.7%) | 5 (20.1%) |
Mixed | 5 (3.6%) | 1 (0.9%) | 4 (16.7%) |
Genetics | |||
Primary aim | 46 (33.1%) | 43 (37.4%) | 3 (12.5%) |
Secondary aim | 45 (32.3%) | 43 (37.4%) | 2 (8.3%) |
Future research | 23 (16.6%) | 12 (10.4%) | 11 (45.8%) |
Not mentioned in protocol/consent | 25 (18.0%) | 17 (14.8%) | 8 (33.3%) |
Age | |||
Adult | 89 (64.0%) | 71 (61.7%) | 18 (75%) |
Child | 15 (10.8%) | 15 (13.0%) | 0 (0.0%) |
Adult, child | 33 (23.7%) | 29 (25.2%) | 4 (16.7%) |
Not available in data | 2 (1.4%) | 0 (0.0%) | 2 (8.3%) |
Investigator Characteristics | n = 130 | n = 106 | n = 24 |
Degree | |||
MD | 83 (63.8%) | 74 (69.8%) | 9 (35.7%) |
MD+ | 24 (18.5%) | 17 (16.0%) | 7 (29.2%) |
PhD | 18 (13.9%) | 11 (10.4%) | 7 (29.2%) |
PhD+ | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Other | 3 (2.3%) | 2 (1.9%) | 1 (4.2%) |
Missing | 2 (1.5%) | 2 (1.9%) | 0 (0.0%) |
Rank | |||
Professor | 64 (49.2%) | 49 (46.2%) | 15 (62.5%) |
Associate professor | 26 (20.0%) | 22 (20.8%) | 4 (16.7%) |
Assistant professor | 26 (20.0%) | 24 (22.6%) | 2 (8.3%) |
Other | 5 (3.9%) | 3 (2.8%) | 2 (8.3%) |
Missing | 9 (6.9%) | 8 (7.6%) | 1 (4.2%) |
Institutional Characteristics | n = 36 | n = 17 | n = 19 |
Public | 18 (50%) | 10 (58.9%) | 8 (42.1%) |
Private | 18 (50%) | 7 (41.1%) | 11 (57.9%) |
Geographic location | — | — | — |
Northeast | 8 (22.2%) | 4 (23.5%) | 4 (21.1%) |
Southeast | 8 (22.2%) | 2 (11.8%) | 6 (31.6%) |
Midwest/central | 9 (25%) | 5 (29.4%) | 4 (21.1%) |
West | 11 (30.6%) | 6 (35.3%) | 5 (26.3%) |